Ram Aiyar serves as the Chief Executive Officer and President of KORRO BIO INC, a pioneering biotechnology company focused on developing innovative therapies for genetic diseases. With a robust background in the life sciences industry, Aiyar has been instrumental in steering KORRO BIO towards groundbreaking advancements in genetic medicine. His leadership is characterized by a strategic vision that emphasizes the translation of scientific discoveries into tangible, life-changing treatments. Prior to his role at KORRO BIO, Aiyar held several key positions in the biotech sector, where he honed his skills in corporate strategy and operational management. He has a proven track record of leading cross-functional teams to successfully bring new therapies from the research phase to market. His tenure at previous companies was marked by significant milestones, including the development and launch of several high-impact pharmaceutical products. Aiyar's expertise in navigating the complex landscape of drug development and regulatory affairs has been a critical asset to KORRO BIO. As CEO and President, Aiyar is responsible for overseeing the company's overall strategy and operations, driving the development of its innovative RNA editing platform, and fostering partnerships that enhance KORRO BIO's capabilities. Under his guidance, the company has made substantial progress in its mission to address unmet medical needs through precision medicine. Aiyar's commitment to advancing the field of genetic therapies continues to inspire his team and the broader scientific community, positioning KORRO BIO as a leader in the biotechnology industry.